NEW YORK, March 29, 2017 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois on behalf of investors who purchased FTD Companies, Inc. (“FTD” or the “Company”) (NASDAQ:FTD) securities between March 13, 2015 and March 14, 2017.
For more information, click here: http://www.zlk.com/pslra/ftd-companies-inc-ftd.
The complaint alleges that the Company made false and/or misleading statements and/or failed to disclose that: (i) FTD’s financial statements contained errors relating to the assessment of cross-border indirect taxes; (ii) in turn, the Company lacked effective internal controls over financial reporting; (iii) FTD had overstated the benefits of the Provide acquisition; and (iv) as a result of the foregoing, FTD’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in FTD you have until May 19, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/ftd-companies-inc-ftd.
Levi & Korsinsky is a national firm with offices in New York, Connecticut, and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (866) 367-6510 www.zlk.com


NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
AFT Leaves X Over AI-Generated Images of Minors
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 



